NCT06471751

Brief Summary

The Obstructive Sleep Apnea hypopnea Syndrome (OSAS), whose prevalence is 4% of the French population, can lead to serious health consequences (risk of road accidents, onset of cardiovascular disease, etc.). OSAS corresponds to a certain number of interruptions (apneas) or reductions (hypopneas) of ventilation during sleep. The weakening of the tone of the inspiratory and oropharyngeal muscles is one of the main causes of upper airways obstruction during the inspiratory phase.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Dec 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Dec 2024Aug 2026

First Submitted

Initial submission to the registry

June 18, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

December 30, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Last Updated

January 29, 2025

Status Verified

January 1, 2025

Enrollment Period

1.6 years

First QC Date

June 18, 2024

Last Update Submit

January 28, 2025

Conditions

Keywords

Inspiratory Muscles TrainingOropharyngeal training

Outcome Measures

Primary Outcomes (1)

  • Apnea-Hypopnea Index (AHI)

    AHI is measured by polygraphy or polysomnography. It is not a score

    At 3 months

Secondary Outcomes (7)

  • Maximum inspiratory pressure measurement (cmH2O)

    At 3 and 9 Months

  • Neck circumference (cm)

    At 3 months

  • Epworth sleepiness score

    At 3 and 9 Months

  • Pittsburgh Sleep quality index

    At 3 and 9 Months

  • Quality of life scale : Short Form 12 (SF12)

    At 3 and 9 Months

  • +2 more secondary outcomes

Study Arms (2)

Strengthening muscles group

EXPERIMENTAL

Home training to strengthen Inspiratory and Oropharyngeal muscles

Other: Inspiratory and Oropharyngeal Muscle Strengthening

No training group

NO INTERVENTION

No intervention

Interventions

Patients will conduct the training at home, 5 days a week for 3 months. They will perform 2 sets of 30 inspirations against resistance (POWERbreathe® K5 , Powerbreathe International Limited, UK), equal to 70% Maximum Inspiratory Pressure (MIP). Patients will be guided for oropharyngeal exercises. The sessions will be supervised by the investigator every 3 weeks. During sessions with the investigator, sessions recorded in the device will be downloaded to verify compliance. A MIP measurement will be performed to adjust the resistance of the device.

Strengthening muscles group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Moderate SAHOS (15 ≤ AHI ≤30);
  • Body Mass Index (BMI) \< 35 ;
  • Patient affiliated or entitled to a social security scheme;
  • Patient having signed a consent to participate in the study.

You may not qualify if:

  • Excessive daytime sleepiness: Epworth sleepiness score \> 10 ;
  • Professional driving and history of accidents related to sleepiness;
  • Severe obstructive or restrictive ventilatory disorders of neuromuscular origin authenticated by respiratory function tests;
  • Patients undergoing treatment for OSAS or requiring immediate initiation of continuous positive airway pressure (CPAP) or a mandibular advancement orthosis;
  • Patients who have stopped CPAP or orthosis treatment in less than one month;
  • Patients undergoing cardiorespiratory exercise rehabilitation or starting regular physical training;
  • Uncompensated heart failure, thoracic sternotomy surgery \< 4 months;
  • Marked osteoporosis with history of rib fractures;
  • History of spontaneous pneumothorax;
  • Severe asthma;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU de Grenoble

Grenoble, 38000, France

NOT YET RECRUITING

Centre Hospitalier Universitaire

Saint-Etienne, 42055, France

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Inhalation

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Respiratory MechanicsRespirationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Amandine Zellag

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amandine ZELLAG, physiotherapist

CONTACT

Pierre LABEIX, physiotherapist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2024

First Posted

June 24, 2024

Study Start

December 30, 2024

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

January 29, 2025

Record last verified: 2025-01

Locations